Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$209.01 - $232.56 $8,151 - $9,069
-39 Reduced 1.3%
2,971 $649,000
Q4 2023

Feb 13, 2024

SELL
$197.69 - $227.29 $90,146 - $103,644
-456 Reduced 13.16%
3,010 $684,000
Q3 2023

Nov 13, 2023

BUY
$201.05 - $221.7 $696,839 - $768,412
3,466 New
3,466 $696,000
Q2 2023

Aug 14, 2023

BUY
$211.93 - $241.33 $391,010 - $445,253
1,845 Added 31.91%
7,626 $1.84 Million
Q1 2023

May 12, 2023

BUY
$213.32 - $257.83 $36,477 - $44,088
171 Added 3.05%
5,781 $1.33 Million
Q4 2022

Feb 13, 2023

SELL
$203.72 - $248.97 $301,098 - $367,977
-1,478 Reduced 20.85%
5,610 $1.32 Million
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $146,234 - $187,203
714 Added 11.2%
7,088 $1.45 Million
Q2 2022

Aug 10, 2022

SELL
$213.86 - $277.87 $485,889 - $631,320
-2,272 Reduced 26.28%
6,374 $1.49 Million
Q1 2022

May 12, 2022

BUY
$259.82 - $298.18 $117,178 - $134,479
451 Added 5.5%
8,646 $2.28 Million
Q4 2021

Feb 10, 2022

SELL
$271.6 - $314.21 $54,048 - $62,527
-199 Reduced 2.37%
8,195 $2.58 Million
Q3 2021

Nov 09, 2021

BUY
$274.82 - $308.34 $88,766 - $99,593
323 Added 4.0%
8,394 $2.36 Million
Q2 2021

Aug 11, 2021

SELL
$251.87 - $278.14 $9,067 - $10,013
-36 Reduced 0.44%
8,071 $2.23 Million
Q1 2021

May 12, 2021

BUY
$204.88 - $255.03 $28,068 - $34,939
137 Added 1.72%
8,107 $2.07 Million
Q4 2020

Feb 12, 2021

SELL
$186.91 - $214.42 $35,886 - $41,168
-192 Reduced 2.35%
7,970 $1.62 Million
Q3 2020

Nov 12, 2020

BUY
$167.03 - $201.3 $23,050 - $27,779
138 Added 1.72%
8,162 $1.54 Million
Q2 2020

Aug 12, 2020

SELL
$113.31 - $182.44 $11,557 - $18,608
-102 Reduced 1.26%
8,024 $1.33 Million
Q1 2020

May 13, 2020

SELL
$104.32 - $195.28 $495,624 - $927,775
-4,751 Reduced 36.9%
8,126 $1.03 Million
Q4 2019

Feb 12, 2020

SELL
$163.48 - $173.61 $212,850 - $226,040
-1,302 Reduced 9.18%
12,877 $2.18 Million
Q3 2019

Nov 12, 2019

BUY
$159.77 - $178.1 $44,575 - $49,689
279 Added 2.01%
14,179 $2.38 Million
Q2 2019

Aug 09, 2019

SELL
$144.16 - $172.9 $693,842 - $832,167
-4,813 Reduced 25.72%
13,900 $2.4 Million
Q1 2019

May 10, 2019

BUY
$123.7 - $156.3 $28,327 - $35,792
229 Added 1.24%
18,713 $2.86 Million
Q4 2018

Feb 08, 2019

BUY
$120.82 - $174.09 $649,890 - $936,430
5,379 Added 41.05%
18,484 $2.34 Million
Q3 2018

Nov 08, 2018

BUY
$167.67 - $188.27 $253,852 - $285,040
1,514 Added 13.06%
13,105 $2.28 Million
Q2 2018

Aug 10, 2018

BUY
$160.33 - $189.41 $361,223 - $426,740
2,253 Added 24.13%
11,591 $2.08 Million
Q1 2018

May 10, 2018

BUY
$161.53 - $178.11 $193,836 - $213,732
1,200 Added 14.75%
9,338 $1.51 Million
Q4 2017

Feb 09, 2018

BUY
$147.99 - $163.95 $82,874 - $91,812
560 Added 7.39%
8,138 $1.3 Million
Q3 2017

Nov 08, 2017

BUY
$149.47 - $160.56 $1.13 Million - $1.22 Million
7,578
7,578 $1.14 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Norinchukin Bank, The Portfolio

Follow Norinchukin Bank, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norinchukin Bank, The, based on Form 13F filings with the SEC.

News

Stay updated on Norinchukin Bank, The with notifications on news.